The opioid peptide analog D-Ala2-Met-enkephalinamide decreases bile flow by a central mechanism

Peptides

Volumn 20, Issue 8, 1999, Pages 979-986

  Bergasa, Nora V ^a   Zhou, Jie ^a   Ravi, Jyotsna ^a   Shi, Qiuhu ^a  

^a BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

Bile flow; Cholestasis; D Ala2 Met enkephalinamide; Naloxone; Opioids

Indexed keywords

METENKEPHALINAMIDE[2 DEXTRO ALANINE]; NALOXONE; OPIATE ANTAGONIST; OPIATE PEPTIDE;

ANIMAL EXPERIMENT; ARTICLE; BILE FLOW; CHEMICAL SYMPATHECTOMY; CISTERNA MAGNA; CONTROLLED STUDY; DENERVATION; INTRACEREBRAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BILE; BLOOD PRESSURE; CHOLESTASIS; CHOLINERGIC ANTAGONISTS; ENKEPHALIN, METHIONINE; GALLBLADDER; MALE; NALOXONE; NARCOTIC ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0032821918     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(99)00091-1     Document Type: Article

References (48)

1. Alpini G., Lenzi R., Sarkozi L., Tavaloni N. Biliary physiology in rats with bile ductular cell hyperplasia. Evidence for a secretory function of proliferated bile ductules. J Clin Invest. 81:1988;569-578.
2. Alpini G., Lenzi R., Sarkozi L., Tavoloni N. Biliary physiology in rats with bile ductular cell hyperplasia. Evidence for a secretory function of proliferated bile ductules. J Clin Invest. 81:1988;569-578.
3. Bergasa N.V., Alling D.W., Talbot T.L., Swain M.G., Yurdaydin C., Schmitt J.M., Walker E.C., Turner M.L., Jones E.A. Naloxone ameliorates the pruritus of cholestasis results of a double-blind randomized placebo-controlled trial . Ann Int Med. 123:1995;161-167.
4. Bergasa N.V., Alling D.W., Vergalla J., Jones E.A. Cholestasis in the male rat is associated with naloxone-reversible antinociception. J Hepatol. 20:1994;85-90.
5. Bergasa N.V., Jones E.A. The pruritus of cholestasis potential pathogenic and therapeutic implications of opioids . Gastroenterology. 108:1995;1582-1588.
6. Bergasa N.V., Talbot T.L., Schmitt J.P., Alling D.W., Swain M.G., Turner M., Jenkins J., Jones E.A. Open label trial of oral nalmefene therapy for the pruritus of cholestasis. Hepatology. 27:1998;679-684.
7. Bueno L., Fioramonti J. Action of opiates on gastrointestinal function. Bailliere's Clin Gastroenterol. 2:1988;123-139.
8. Dockray G.J. Regulatory peptides and the neuroendocrinology of brain gut relations. Q J Ex Physiol. 73:1988;703-727.
9. Erlinger S. Bile flow. Arias I.M. The liver biology and pathobiology. 1994;769-788 Raven Press, New York.
10. Garcia-Marin J.J., Dumont M., Corbic M., de Couet G., Erlinger S. Effect of acid-base balance and acetazolamide on ursodeoxycholate-induced biliary bicarbonate secretion. Am J Physiol. 11:1985;G20-G27.
11. SAS/STAT user's guide, 6.03 Ed. 1988;SAS Institute Inc, Cary, NC.
12. Glaser S.S., Rodgers R.E., Phinizy J.L., Robertson W.E., Lasater J., Caligiuri A., Tretjak Z., LeSage G.D., Alpini G. Gastrin inhibits secretin-induced ductal secretion by interaction with specific receptors on rat cholangiocytes. Am J Physiol. 273:1997;G1061-G1070.
13. Green P.G., Luo J., Heller P.H., Levine J.D. Further substantiation of a significant role for the sympathetic nervous system in inflammation. Neuroscience. 55:1993;1037-1043.
14. - secretion in the pig. Acta Physiol Scand. 131:1987;181-193.
15. Grotmol T., Buanes T., Sørensen H., Raeder M.G. Effects of bumetanide on bile flow in the pig. Acta Physiol Scan. 133:1988;391-397.
16. Hassen A.H., Feuerstein G. μ-Opioid receptors in NTS elicit pressor responses via sympathetic pathways. Am J Physiol. 252:1987;H156-H162.
17. Hawkins K.N., Knapp R.J., Gehlert D.R., Lui G.K., Yamamura M.S., Roeske L.C., Hruby V.J., Yamamura H.I. Quantitative autoradiography of [3H]CTOP binding to mu opioid receptors in rat brain. Life Sciences. 42:1988;2541-2551.
18. Hurwitz A., Looney G., Sullins M., Ben-Zvi Z. Hepatobiliary effects of morphine are mediated in the brain. Hepatology. 12:1990;1406-1412.
19. Jaffe J., Martin W. Opioid analgesics and antagonists. Gilman A., Goodman L., Rall T. The pharmacologic basis of therapeutics, 7th ed. 1985;491-531 Macmillan, New York.
20. Kelinbaum D.G., Kupper L.L., Muller K.E. Applied regression analysis and other multivariate methods. 1988;PWS-Kent Publishing, Boston.
21. Lautt W.W. Afferent and efferent neural roles in liver function. Prog Neurobiol. 21:1983;323-348.
22. Mansour A., Fox C.A., Burke S., Meng F., Thompson R.C., Akil H., Watson S.J. Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS an in situ hybridization study . J Comp Neurol. 350:1994;412-438.
23. Martinez V., Taché Y. Brain control of gastric acid secretion experimental methods of approach . Gaginella T.A. Handbook of methods in gastrointestinal pharmacology. 1996;37-61 CRC Press, New York.
24. Matsumura T., Sato N., Kawano S., Hijoko T., Eguchi H., Kamada T. Effect of hepatic blood oxygenation on bile secretion in rats. Adv Exp Med Biol. 222:1988;585-589.
25. 5-enkephalin-immunoreactive terminals to vagal motor neurons in the nucleus ambiguus comparison with the dorsal motors nucleus of the vagus . J Comp Neurol. 353:1995;391-406.
26. Nathanson M.H., Boyer J.L. Mechanisms and regulation of bile secretion. Hepatology. 14:1991;551-566.
27. 2]-Met-enkephalinamide. Science. 194:1976;330-332.
28. Reichen J., Simon F. Cholestasis. Arias I.M., Jakoby W.B., Popper H., Schachter D., Schafrits D.A. The liver biology and pathobilogy, 2nd ed . 1988;1105-1124 Raven Press, New York.
29. Roskams T, de Vos R, Joost >JVDO, Desmet V. Cells with neuroendocrine features in regenerating human liver. APMIS Suppl 1991;23:32-9.
30. Roskams T., van den Oord J., De Vos R., Desmet V. Neuroendocrine features of reactive bile ductules in cholestatic liver disease. Am J Pathol. 13:1990;1019-1025.
31. Roze C., Dubrasquet M., Chariot J., Vaille C. Central inhibition of basal pancreatic and gastric secretions by β-endorphin in rats. Gastroenterology. 79:1980;659-664.
32. Sawchenko P.E., Friedman M. Sensory functions of the liver - a review. Am J Physiol. 236:1979;R5-R20.
33. Siaud P., Mekaouche M., Givalois L., Balmefrezol M., Marcilhac A., Ixart G. Effects of pharmacological lesion of adrenergic innervation of the dorsal vagal nucleus on pancreatic insulin secretion in normal and vagotomized rats. Physiol Res. 44:1995;227-231.
34. Siaud P., Puech R., Assenmacher I., Alonso G. Adrenergic innervation of the dorsal vagal motor nucleus possible involvement in inhibitory control of gastric acid and pancreatic insulin secretion . Cell Tissue Res. 259:1990;535-542.
35. Spivey J., Jorgensen R., Gores G., Lindor K. Methionine-enkephalin concentrations correlate with stage of disease but not pruritus in patients with primary biliary cirrhosis. Am J Gastroenterol. 89:1994;2018-2032.
36. Tavoloni N., Schaffner F. The intrahepatic biliary epithelium in the guinea pig is hepatic artery blood flow essential in maintaining its function and structure? Hepatology. 5:1985;666-672.
37. Tepperman F.S., Hirst M., Smith P. Brain and serum levels of naloxone following peripheral administration. Life Sci. 33:1983;1091-1096.
38. 2 Methionine and Leucine enkephalinamide, and methionine and leucine enkephalinamide. Peptides. 6:1985;1253-1256.
39. Thornton J.R., Losowsky M.S. Opioid peptides and primary biliary cirrhosis. Br Med J. 297:1988;1501-1504.
40. Thornton J.R., Losowsky M.S. Plama methionine enkephalin concentration and prognosis in primary biliary cirrhosis. Br Med J. 297:1988;1241-1242.
41. Tietz P.S., Alpini G., Pham L.D., Larusso N.F. Somatostatin inhibits secretin-induced ductal hypercholeresis and exocytosis by cholangiocytes. Am J Physiol. 269:1995;G110-G118.
42. 2-Met-enkephalinamide, in rats. Neuroendocrinology. 33:1981;153-157.
43. Van Loon G.R., Appel N.M. B-endorphin-induced increases in plasma dopamine, norepinephrine and epinephrine. Res Commun Chem Pathol Pharmacol. 27:1980;607-610.
44. Weinstein S.H., Pfeffer M., Schor J.M. Metabolism and pharmacokinetics of naloxone. Adv Biochem Psychopharmacol. 8:1973;525-535.
45. Wennberg E., Hagberg H., Haljamae H. The response of the awake spontaneously hypertensive rat (SHR) to acute blood loss. Acta Anaesthesiol Scand. 28:1984;457-461.
46. Xia Y., Haddad G.G. Ontogeny and distribution of opioid receptors in the rat brainstem. Brain Res. 549:1991;181-193.
47. Yoneda M., Tamasawa N., Takebe K., Tamori K., Yokohama S., Sato Y., Nakamura K., Makino I., Tache Y. Central neuropeptide Y enhances bile secretion through vagal and muscarinic but not nitric oxide pathways in rats. Peptides. 16:1995;727-732.
48. Yoneda M., Yokohama S., Tamori K., Sato Y., Nakamura K., Makino I. Neuropeptide Y in the dorsal vagal complex stimulates bicarbonate-dependent bile secretion in rats. Gastroenterology. 112:1997;1673-1680.